Price $1.20 |
Market Cap
17.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
-
|
Dividend %
-
|
|
P/CF
11.7
|
P/FCF
-
|
Op. Cash Flow
-4.8K
|
FCF
-0.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-
|
|
ROA
-146.20%
|
EPS Growth
12.30%
|
Current Ratio
1.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bovie Medical Corporation (BVX) | $4.11 | - | - | 128.9M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| Pernix Therapeutics Holdings I (PTX) | $2.55 | - | - | 27.5M | Strong Buy |
| Senomyx Inc. (SNMX) | $1.21 | - | - | 65.7M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
